Aline G. Santana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aline G. Santana has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Franco Paes Leme
Advanced Clusters in Health Technologies (NATS), Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, São Paulo, Brazil
2 shared publications - Carlos César Bof Bufon
Physics Department Institute of Geosciences and Exact Sciences São Paulo State University (UNESP) Rio Claro São Paulo 13506‐900 Brazil
2 shared publications - Davi Henrique Starnini de Camargo
Brazilian Nanotechnology National Laboratory (LNNano), Brazilian Center for Research in Energy and Materials (CNPEM), 13083-970 Campinas, São Paulo, Brazil
2 shared publications - Luciana Daniele Trino
Centro de Tecnologia da Informação Renato Archer, Campinas, SP 13069-901 Brazil
2 shared publications - Luiz Gustavo Simão Albano
Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, Sao Paulo, 13083-970, Brazil
2 shared publications - Ana Carolina Prado-Ribeiro
Serviço de Odontologia Oncológica, Instituto Do Câncer Do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo São Paulo Brazil
1 shared publication
Latest Publications
- Open Access
Noninvasive and Sensitive Biosensor for the Detection of Oral Cancer Prognostic Biomarkers
Early detection of oral squamous cell carcinoma (OSCC) significantly enhances treatment outcomes and survival rates, with lymph node metastasis serving as a main prognostic factor. However, current clinical practices rely on TNM classification, including histological confirmation of metastatic disease in lymph nodes, often involving elective neck dissection, a procedure that can cause post‐operative morbidity. Here it is shown that zinc imidazole framework‐8 (ZIF‐8) electrochemical biosensors can effectively distinguish non‐metastatic (N0) from lymph node metastatic (N+) OSCC saliva samples. By monitoring the OSCC biomarkers cystatin B (CSTB), leukotriene A 4 hydrolase (LTA4H), and collagen type VI alpha 1 chain (COL6A1) in human saliva through electrochemical impedance spectroscopy and antigen–antibody immunoreactions, elevated biomarker levels in N0 samples are observed. The biosensor displays high accuracy, specificity, and reproducibility, with limits of detection lower than 0.4 ng mL −1 . Supervised bioinformatic analysis, using 34 machine learning classifiers, indicates LTA4H as the most accurate biomarker for distinguishing prognostic groups, confirming previous mass spectrometry findings. Notably, the AdaBoost model, integrating the combined detection of biomarkers, achieves a 76% accuracy rate in identifying metastatic saliva samples. This non‐invasive biosensor technology, combined with bioinformatics, presents a sensitive and reliable approach to improve clinical assessments and guiding therapeutic decisions for OSCC patients.
Open AccessNoninvasive and Sensitive Biosensor for the Detection of Oral Cancer Prognostic Biomarkers
Early detection of oral squamous cell carcinoma (OSCC) significantly enhances treatment outcomes and survival rates, with lymph node metastasis serving as a main prognostic factor. However, current clinical practices rely on TNM classification, including histological confirmation of metastatic disease in lymph nodes, often involving elective neck dissection, a procedure that can cause post‐operative morbidity. Here it is shown that zinc imidazole framework‐8 (ZIF‐8) electrochemical biosensors can effectively distinguish non‐metastatic (N0) from lymph node metastatic (N+) OSCC saliva samples. By monitoring the OSCC biomarkers cystatin B (CSTB), leukotriene A 4 hydrolase (LTA4H), and collagen type VI alpha 1 chain (COL6A1) in human saliva through electrochemical impedance spectroscopy and antigen–antibody immunoreactions, elevated biomarker levels in N0 samples are observed. The biosensor displays high accuracy, specificity, and reproducibility, with limits of detection lower than 0.4 ng mL −1 . Supervised bioinformatic analysis, using 34 machine learning classifiers, indicates LTA4H as the most accurate biomarker for distinguishing prognostic groups, confirming previous mass spectrometry findings. Notably, the AdaBoost model, integrating the combined detection of biomarkers, achieves a 76% accuracy rate in identifying metastatic saliva samples. This non‐invasive biosensor technology, combined with bioinformatics, presents a sensitive and reliable approach to improve clinical assessments and guiding therapeutic decisions for OSCC patients.
- 10 February 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (4) , 1293-1306
ZIF-8 Metal–Organic Framework Electrochemical Biosensor for the Detection of Protein–Protein Interaction
- 10 February 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (4) , 1293-1306
ZIF-8 Metal–Organic Framework Electrochemical Biosensor for the Detection of Protein–Protein Interaction
- 28 June 2017
- Published by Springer Nature
- p. 281-288
Nuclear Proteomics for Exploring MK-801-Treated Oligodendrocytes to Better Understand Schizophrenia
- 28 June 2017
- Published by Springer Nature
- p. 281-288
Nuclear Proteomics for Exploring MK-801-Treated Oligodendrocytes to Better Understand Schizophrenia